Sab, Dic 4, 2021

Dalla letteratura internazionale

Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo

Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo

Abstract
Effective and economic measures are needed to either prevent or inhibit the replication of SARS-CoV-2, the causative agent of COVID-19, in the upper respiratory tract. As fumigation of vinegar at low concentration (0.34%) ameliorated the symptoms of mild SARS- CoV-2 infection, we tested in vitro the potential antiviral activity of vinegar and of its active component, acetic acid.
We here demonstrate that both vinegar and acetic acid indeed strongly inactivate SARS-CoV-2 infectivity in Vero cells. Furthermore, vinegar treatment caused a 90% inhibition of the infectious titer when directly applied to a nasopharyngeal swab transfer medium of a
COVID-19 patient. These effects were potentiated if conduced at a temperature of 45°C vs. 37°C, a condition that is transiently generated in the upper respiratory tract during fumigation. Our findings are consistent and extend the results of studies performed in the early and mid-20th century on the disinfectant capacity of organic acids and can provide an affordable home-made aid to prevent or contain SARS-CoV-2 infection of the upper respiratory tract.

Altri articoli


Rimani aggiornato con la Newsletter

Abilita il javascript per inviare questo modulo

Cliccando su "iscriviti" accetti di ricevere la newsletter della nostra Fondazione e confermi di aver letto la Privacy Policy